Eric Schwartz
Impact in
- Molecular Medicine top 5%
- Curcumin's Biomedical Applications
- Oncology top 10%
- Cytokine Signaling Pathways and Interactions
Papers in
- Oncology 8
- Cytokine Signaling Pathways and Interactions 4
- Co-authors
- James R. Fuchs (11 shared papers)Pui‐Kai Li (6 shared papers)Chenglong Li (7 shared papers)Jiayuh Lin (5 shared papers)Devin G. Peterson (5 shared papers)Gregory B. Lesinski (4 shared papers)Laurianne Paravisini (2 shared papers)Li Lin (3 shared papers)
- Journals
- Food Chemistry (4 papers)Gastrointestinal Endoscopy (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Molecular Cancer (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Eric Schwartz
30 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 100
- Molecular Medicine 151
- Oncology 295
- Pathology and Forensic Medicine 146
- Biotechnology 63
- Toxicology 21
Countries citing papers authored by Eric Schwartz
This map shows the geographic impact of Eric Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Schwartz more than expected).
Fields of papers citing papers by Eric Schwartz
This network shows the impact of papers produced by Eric Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Schwartz. The network helps show where Eric Schwartz may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Schwartz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 127 | |
| 2 | 2010 | 100 | |
| 3 | 2008 | 86 | |
| 4 | 2011 | 79 | |
| 5 | 2013 | 75 | |
| 6 | 2021 | 74 | |
| 7 | 2012 | 71 | |
| 8 | 2019 | 60 | |
| 9 | 2015 | 56 | |
| 10 | Pro-growth role of the JMJD2C histone demethylase in HCT-116 colon cancer cells and identification of curcuminoids as JMJD2 inhibitors. | 2014 | 53 |
| 11 | 2010 | 52 | |
| 12 | 2011 | 49 | |
| 13 | 2012 | 38 | |
| 14 | 2020 | 28 | |
| 15 | 1995 | 21 | |
| 16 | 2021 | 21 | |
| 17 | 2005 | 16 | |
| 18 | 2021 | 14 | |
| 19 | 2022 | 11 | |
| 20 | 2002 | 8 |
About Eric Schwartz
Eric Schwartz is a scholar working on Molecular Biology, Oncology, Surgery, Pulmonary and Respiratory Medicine and Food Science, having authored 30 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (4 papers), Meat and Animal Product Quality (3 papers), Fermentation and Sensory Analysis (3 papers), Sarcoma Diagnosis and Treatment (2 papers), Ferroptosis and cancer prognosis (2 papers), Coffee research and impacts (2 papers), Neurofibromatosis and Schwannoma Cases (2 papers) and Food Chemistry and Fat Analysis (2 papers). The work is most often cited by research in Molecular Medicine (151 citations), Oncology (295 citations), Pathology and Forensic Medicine (146 citations), Biotechnology (63 citations) and Toxicology (21 citations). Eric Schwartz has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include James R. Fuchs, Pui‐Kai Li, Chenglong Li, Jiayuh Lin, Devin G. Peterson, Gregory B. Lesinski, Laurianne Paravisini, Li Lin, Dale G. Hoyt and Stacey Fossey. Their work appears in journals such as Food Chemistry, Gastrointestinal Endoscopy, Journal for ImmunoTherapy of Cancer, Molecular Cancer and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.